HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 80464810570

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80464810570 and manufactured by manufacturer not specified. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until May 14, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80464810570
2 Related Devices
Registration Details
ANVISA Registration Number: 80464810570
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

NovaLisa® Avidity Cytomegalovirus (CMV) IgG
Risk Class IV

Registration Details

80464810570

25351722657201729

09377976000152

Dates and Status

May 14, 2018

14/05/2028

09/18/2025 19:00:01

NovaLisa® Avidity Cytomegalovirus (CMV) IgG
Risk Class IV

Registration Details

80464810570

25351722657201729

09377976000152

Company Information

Germany
PT: ALEMANHA

Dates and Status

May 14, 2018

14/05/2028

09/18/2025 19:00:01